Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Fernandes (Matosinhos, Portugal), B. Cabrita (Matosinhos, Portugal), S. Dias (Matosinhos, Portugal), J. Ferreira (Matosinhos, Portugal), I. Neves (Matosinhos, Portugal). Chronic Hypersensitivity Pneumonitis and mortality: impact of comorbidities. 3001

Member's Comments

No comment yet.

Related content which might interest you: Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Chronic Hypersensitivity pneumonitis: risks factors and therapeutic options Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Progressive Phenotype in Chronic Hypersensitivity Pneumonitis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Exacerbations of bronchiectasis: Etiology and outcome Source: International Congress 2016 – Orphan diseases II Year: 2016 Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis Source: Eur Respir J, 51 (6) 1800430; 10.1183/13993003.00430-2018 Year: 2018 Pulmonary hemodynamics and mortality in chronic hypersensitivity pneumonitis Source: International Congress 2017 – Rare diseases Year: 2017 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Determinants and assessment of excess cardiovascular risk in bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Antifibrotic treatment in 18 patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 30-day Readmissions After Acute Exacerbations of COPD: How Relevant Are Comorbidities? Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015